Login

$RLAY SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G
04 Nov 2026 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition

Phase 3 ReDiscover-2 trial in 2L breast cancer expected to complete enrollment in mid-2027

30 Oct 2026 Form 4: Rahmer Peter, See remarks

Sold 753 shares ($14K)

30 Oct 2026 Form 4: Bergstrom Donald A, President, R&D

Sold 2,252 shares ($41.9K)

30 Oct 2026 Form 4: Catinazzo Thomas, Chief Financial Officer

Sold 1,469 shares ($27.4K)

08 Oct 2026 Form 4: Patel Sanjiv, Director

Sold 48,199 shares ($872K)

08 Oct 2026 Form 4: Catinazzo Thomas, Chief Financial Officer

Sold 17,717 shares ($329K)

07 Oct 2026 144
06 Oct 2026 144
09 Sep 2026 Form 4: Bergstrom Donald A, President, R&D

Sold 8,530 shares ($162K)

09 Sep 2026 Form 4: Catinazzo Thomas, Chief Financial Officer

Sold 17,717 shares ($336K)

09 Sep 2026 Form 4: Patel Sanjiv, Director

Sold 48,199 shares ($913K)

28 Aug 2026 Form 4: Rahmer Peter, See remarks

Sold 4,508 shares ($90.3K)

28 Aug 2026 Form 4: Svf Pauling (Cayman) Ltd, 10% owner and 2 others

Sold 6,000,000 shares ($116M)

26 Aug 2026 144
25 Aug 2026 144
18 Aug 2026 Form 4: Patel Sanjiv, Director

Sold 48,199 shares ($980K)

18 Aug 2026 Form 4: Catinazzo Thomas, Chief Financial Officer

Sold 17,717 shares ($350K)

14 Aug 2026 SCHEDULE 13G/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support